| Names | |
|---|---|
| Preferred IUPAC name | 1-(3-(Trifluoromethyl)phenyl)ethan-1-one |
| Pronunciation | /ɛm-traɪˌfluːrəˌmɛθəlˌæsɪtoʊfəˈnoʊn/ |
| Identifiers | |
| CAS Number | 535-05-3 |
| 3D model (JSmol) | `CCC(=O)C1=CC(=CC=C1)C(F)(F)F` |
| Beilstein Reference | 1208733 |
| ChEBI | CHEBI:77801 |
| ChEMBL | CHEMBL142099 |
| ChemSpider | 21706 |
| DrugBank | DB04184 |
| ECHA InfoCard | 03b080fd-d081-48aa-b8cc-e1ad3994f24b |
| EC Number | 212-702-8 |
| Gmelin Reference | 82138 |
| KEGG | C19322 |
| MeSH | D015640 |
| PubChem CID | 70100 |
| RTECS number | AM7240000 |
| UNII | JI7RU1H9AK |
| UN number | UN1993 |
| CompTox Dashboard (EPA) | DTXSID40889123 |
| Properties | |
| Chemical formula | C9H7F3O |
| Molar mass | 182.15 g/mol |
| Appearance | Colorless to pale yellow liquid |
| Odor | Aromatic |
| Density | 1.26 g/cm3 |
| Solubility in water | Insoluble |
| log P | 1.9 |
| Vapor pressure | 0.7 mmHg (20°C) |
| Acidity (pKa) | pKa ≈ 18.4 |
| Basicity (pKb) | 11.61 |
| Magnetic susceptibility (χ) | -46.3e-6 cm³/mol |
| Refractive index (nD) | 1.5070 |
| Viscosity | 1.42 mPa·s (25°C) |
| Dipole moment | 2.76 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 332.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -552.8 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -1592.6 kJ/mol |
| Hazards | |
| Main hazards | Harmful if swallowed, causes serious eye irritation, causes skin irritation |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07, GHS05 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P261, P280, P305+P351+P338, P304+P340, P312 |
| Flash point | 64 °C |
| Autoignition temperature | 370 °C |
| Lethal dose or concentration | LD50 oral rat 2104 mg/kg |
| LD50 (median dose) | LD50 (median dose): 1880 mg/kg (oral, rat) |
| NIOSH | SKH21000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.2 ppm (as an 8-hour TWA) |
| IDLH (Immediate danger) | Unknown |
| Attribute | Description / Commentary |
|---|---|
| Product Name | m-Trifluoromethylacetophenone |
| IUPAC Name | 1-[3-(Trifluoromethyl)phenyl]ethan-1-one |
| Chemical Formula | C9H7F3O |
| Synonyms & Trade Names | 3'-Trifluoromethylacetophenone, m-(Trifluoromethyl)acetophenone 1-Acetyl-3-(trifluoromethyl)benzene |
| HS Code & Customs Classification |
Chemicals of this type are typically classified under HS Code 2914.40, which covers ketones and quinones. Exact sub-classification depends on local customs catalogues and final product form. Regulatory analysts usually cross-check the molecular structure against system codes for import/export documentation. |
| Aspect | Manufacturer Commentary |
|---|---|
| Grade and Application Sensitivity |
m-Trifluoromethylacetophenone is used as an intermediate in pharmaceutical, agrochemical, and specialty chemical synthesis. Purity, residual solvents, and byproduct levels vary depending on the required application and downstream usage. Multi-ton scale production generally operates to custom-tailored impurity profiles as specified by strategic end-users; for example, appearance or melting profile audit thresholds are defined in the project validation stage and cannot be generalized across all grades. |
| Raw Material Selection | Raw acetophenone, trifluoromethylbenzenes, and halogenated intermediates form the intake pool. Source reliability, trace metal baseline, and potential impurity carriage (such as halide or organic acid residues) affect both final purity and stepwise yield. Suppliers undergo pre-audit, verification batch testing, and risk qualification to prevent supply disruptions. |
| Process Route and Control Points |
Multiple process routes exist, each with distinct emissions and cost profiles. Friedel–Crafts acylation and organometallic coupling routes differ in terms of byproduct spectrum and separations challenge. Operator training focuses on continuous monitoring of temperature and catalyst load to manage side reactions, with frequent in-process gas/liquid chromatography for real-time feedback. |
| Impurity Generation and Purification |
Key sources of impurities include homologue over-reaction, polymeric tars, or unreacted acetophenone. Dedicated phase filtration, vacuum distillation, or column purification units handle these depending on project scope. Each batch undergoes intermediate sampling for impurity profiling, which guides further special treatments when specification drift is detected. |
| Batch Consistency and Release Criteria | Lot-to-lot consistency is managed through standardized control charts and process capability studies. Final release is based on internal QC criteria and customer-specific requirements, particularly for pharmaceutical or advanced material supply contracts. Final certificate of analysis reflects all relevant physical and chemical indices according to the contract specification. |
m-Trifluoromethylacetophenone remains stable in sealed packaging under controlled ambient warehouse conditions. Degradation triggers typically include prolonged exposure to heat, moisture ingress, or contamination from incompatible storage materials. Container choice and pallet configuration depend on both the hazard class and logistics chain constraints; regulatory-compliant labelling and SDS shipment accompaniment is standard practice.
Manufacturing feedback consistently highlights that trace impurities, if left unchecked, may affect reactivity in secondary synthesis, with knock-on impacts on both process yield and environmental control requirements downstream.
Industrial-grade m-Trifluoromethylacetophenone typically appears as a colorless to pale yellow liquid at ambient temperature. Aromatic odor is common. Form varies with purity and storage; trace discoloration may signal exposure to air or light in less stabilized material, mostly affecting downstream quality when color thresholds matter.
Exact physical constants such as melting point, boiling point, and density shift with grade and residual solvent level. Higher purity and lower moisture content keep physical property range within a tight spread; fractions with more impurities display wider deviations. End-users in pharma and agro targets may demand tighter analytics, which constrains allowable ranges.
Industrial experience shows m-Trifluoromethylacetophenone resists slow hydrolysis under neutral or dry storage but reacts under alkaline or acidic catalysis, especially at elevated temperature. Impurities that enhance acidity or nucleophilicity complicate purification and sometimes alter shelf life. Storage with headspace management helps limit decomposition and odor formation.
The product dissolves in most organic solvents with moderate to high polarity, including ethers, alcohols, and acetone. Solubility in water is limited, which affects selection of solvent mixtures for high-purity crystallizations or reaction setups. Users must check compatibility with process solvents to avoid precipitation or emulsion formation; warming may be needed for concentrated solutions.
Specifications change based on downstream requirements such as pharmaceutical or fine chemical uses. Purity (GC or HPLC), water content (Karl Fischer), and color (APHA/Hazen) are most frequently controlled parameters. Each batch must meet the release standard determined jointly by internal controls and, if applicable, customer specification. Typical values depend on grade and application.
Major impurities include regioisomeric trifluoromethylacetophenones, residual starting benzene derivatives, and byproduct acids. Impurity limits are based on toxicological and performance risks in downstream applications. Process-specific profiles dictate whether secondary purification is necessary for sectors with stringent impurity thresholds, like pharma actives or high-performance materials.
Analytical controls rely on validated chromatographic and spectroscopic methods. Chromatography monitors purity and impurities; specific test methods vary by intended use and region. Internal method validation backs every batch release, ensuring repeatability and accuracy for regulated supply chains.
Benzene derivatives and sources of trifluoromethyl group are core inputs. Sourcing prioritizes high assay, consistent supply chains, and contaminant control, as trace contamination in either raw material leads to persistent impurities.
Typical synthesis uses Friedel-Crafts acylation with meta-substituted precursors and a specialized trifluoroacetyl donor. Route selection depends on regional availability of reagents and waste minimization strategy. Catalyst choice and stoichiometry directly affect both yield and downstream purification cost.
Temperature, reaction time, and catalyst loading are actively monitored. Side reactions generating isomers or polymeric materials are minimized through fine-tuning. Purification involves distillation or crystallization, with an intermediate analytical check for breakthrough impurities.
Batch identity, purity, and key impurity thresholds set the benchmarks for release. In-process tests include GC monitoring and weight balance reconciliation. Out-of-specification batches undergo controlled reprocessing or are downgraded, depending on business policy and technical feasibility.
Reaction partners include nucleophiles for modification at the carbonyl, as well as substitution on the aromatic ring. Industrial conversions often leverage the trifluoromethyl group’s effect on reactivity, guiding selectivity and downstream process yields.
Solvent, catalyst, and temperature choices are determined by the derivative sought. Milder conditions favor preservation of the trifluoromethyl unit, while more robust catalysts or higher temperatures broaden modification options but can trigger side reactions.
Derivative profiles are application-specific; common outputs include pharmaceutical intermediates, fluorinated building blocks, and advanced agricultural actives. Each target sets unique process performance parameters, often driving custom purification and release criteria at the manufacturing stage.
Material stability is sensitive to light and moisture, so low-light, dry, and temperature-controlled storage prolongs shelf life. Drum material must not catalyze decomposition or leach contaminants. Headspace management by nitrogen padding prevents oxidation for sensitive grades.
Metal or fluoropolymer-lined containers are preferred. Direct contact with reactive metals or unlined plastics increases risk of contamination and degradation.
Confirmed shelf life depends on grade and local storage practice. Early discoloration, off-odor, or phase separation usually signals degradation or improper storage. Regular testing supports continued suitability for high-value applications.
Product usually falls under GHS hazardous substance regulations based on flammability, potential environmental impact, and irritation risk. Final hazard classification must reference actual certificate of analysis and SDS for the supplied lot.
Acute exposure can cause respiratory and skin irritation. Chronic data and workplace exposure guidelines are process- and jurisdiction-dependent, enforced by regular industrial hygiene monitoring where applicable. Engineering controls, personal protective equipment, and targeted ventilation are standard practice.
Current production capacity for m-Trifluoromethylacetophenone hinges primarily on upstream supply of trifluoromethyl benzene derivatives and acetophenone-based feedstocks. Output volumes generally fluctuate with both raw material market trends and downstream demand from pharmaceutical and fine chemical segments. Multi-step synthesis routes, reliant either on Friedel–Crafts acylation or custom halogenation, require careful process scheduling: capacity limits often reflect both reactor throughput and purification bottlenecks. Most new customer volume can be supported with adequate forecast lead time, but abrupt surges in demand may encounter scheduling delays due to campaign-based manufacturing or intermediate purification constraints.
Lead time varies based on product grade, required volume, and purification needs; standard commercial grade often ships within four to six weeks from firm order, contingent on raw material receipt and ongoing batch commitments. Minimum order quantity (MOQ) depends on both operational batch size and downstream end use; for R&D applications, laboratory packaging may be considered, subject to higher per-unit handling costs. Most industrial-grade orders require a MOQ in line with efficient reactor charge scale and packaging lot size.
Chosen packaging materials reflect chemical sensitivity, regulatory obligation, and transportation mode. 20–200 kg drums form the bulk of commercial packaging; lined steel drums or fluoropolymer containers provide resistance against halogenated organic solvents. Special requirements for purity-sensitive grades may dictate custom vacuum-sealed or inerted drum packaging. Small-volume R&D lots can ship in glass or high-purity plastic containers.
Standard shipments are offered FOB main port in Asia or EXW plant, with international shipping coordinated per Incoterms. Chemical compatibility, destination regulatory status, and labeling requirements are considered for all logistic routes. Payment terms align with industry practice, balancing customer standing and export finance requirements; negotiable payment is possible for regular accounts, but prepayment may apply for new customers or R&D lots.
The cost of m-Trifluoromethylacetophenone production is dominated by both trifluoromethylating reagents and specialty acetophenone derivatives. Most cost volatility arises from upstream fluoroaromatic intermediates, which rely on global fluorochemical supply chains. Regulatory changes in fluorine chemical production, local restrictions, and shifts in feedstock price for fluorine donors (e.g., HF, TFA) often directly translate to raw material costs. Energy prices indirectly impact costs, especially where distillation or cryogenic purification is significant. Expanded use of continuous manufacturing or local sourcing can help contain cost swings, but major market disruptions affect all grades to varying degrees.
Pricing strictly follows product grade, purity, and specific certification requirements. Intermediate grades for industrial use have lower cost structures owing to relaxed impurity content, whereas pharmaceutical synthesis and electronics sectors demand higher purity specifications and validated analytical documentation, resulting in substantial price deltas. Custom packaging, third-party audit certification, or analytical batch testing add tiered surcharges. Regulatory and environmental audit costs for high-purity routes reflect directly in premium grade pricing.
The grade has the largest influence on unit price per kilogram. Impurities such as ortho- or para-isomers, unreacted starting materials, and halogenated byproducts are tightly controlled in API-intermediate grades; each fraction removed at purification incrementally increases both plant overhead and analytical load. Certifications like GMP, ISO, or REACH drive up both fixed and variable costs due to documentation, lot traceability, and external audit fees. Special packaging, such as low-metal containers and gas-barrier drum liners, further distinguishes price per grade.
Steady demand tracks pharmaceutical and specialty intermediate growth in the US, EU, and Japan, with China and India representing both major production and downstream consumption centers. Local disruptions (feedstock rationing, environmental restrictions, or logistics slowdowns) introduce regional price differentials, especially where import dependency is strong. New applications in agrochemical and advanced material synthesis marginally increase demand, but the primary volume remains within regulated fine chemical chains.
In the US and EU, environmental compliance standards and controlled substance regulations set both sourcing practices and available grade spectrum. Regulatory stringency can tighten supply, especially for electronics-grade and pharmaceutical intermediates. Japanese manufacturers emphasize batch-to-batch reproducibility and documentation, driving premium pricing. India and China lead in bulk production due to established upstream sites, but both economies increasingly face local scrutiny on fluorochemical emissions and effluent controls. Regional lead times and price points in China often reflect access to fluorine feedstocks and export logistics efficiency.
As regulatory tightening on fluorinated intermediates expands globally, cost pressure on raw materials is likely to persist through 2026. Greater transparency in upstream supply chains, local government intervention in waste management, and energy market volatility provide upward price momentum, particularly for pharmaceutical and high-purity grades. Bulk commodity volumes may see flatter escalation, with spot shortages driving temporary premiums. Industry practice suggests forward contracts and multi-year partnership agreements help hedge against sharp swings.
Price analysis draws from in-house procurement records, customer purchase trends, benchmarked international import/export tariffs, and regular monitoring of fluorine chemical feedstock markets. Market intelligence is corroborated with published trade association data, regulatory gazette updates, and verified downstream manufacturing demand scenarios. Any regional forecasts reference actual shipment flow and production expansion commitments from licensed capacity operators.
Increased enforcement of environmental emissions in China has constrained the supply of certain trifluoromethyl precursors, causing both lead time extension and short-term supplier rationing. Legal and environmental scrutiny around halogenated effluent disposal has prompted a shift towards continuous or closed-loop processing at several major sites.
Revised classification of trifluoromethylated intermediates in the EU under registration and authorization frameworks places a premium on complete dossier management. US state-level reporting obligations on persistent organic pollutants have begun to impact batch documentation requirements. Domestic standards in India and China increasingly require traceability in both source and environmental handling.
Manufacturers reduce volatility by diversifying raw material sources and investing in process intensification to control impurity profiles more tightly. Strategic raw material inventory hedging, expanded analytical capacity, and regular process audits form the backbone of supply assurance programs. Early customer engagement for forecast-based production planning remains a proven approach to minimizing both price and delivery risk for specialized grades.
m-Trifluoromethylacetophenone serves as a core building block in a range of synthesis applications. Producers in pharmaceutical and agrochemical sectors look to this molecule for its reactivity in introducing trifluoromethyl groups, which often enhance biological activity and metabolic robustness. Intermediate manufacturers rely on the product’s compatibility in fine chemical transformations, especially in Friedel-Crafts acylation and subsequent nucleophilic substitutions.
Laboratory, pilot, and production environments each demand material consistency. In route scouting or scale-up for pharma APIs, pilot or kilo-lab chemists typically evaluate several grades to identify impact on downstream purity. In crop protection active ingredient synthesis, solvent residue and trace metal levels may weigh heavier in purchase decisions than minor organic byproducts, since these can persist through multiple synthetic steps or interact with catalyst systems. Electronic chemical formulators seeking low ionic content tend to request the tightest control over alkali/alkali earth metal contamination.
| Application | Grade Preference | Reason for Fit | Grade-Dependent Risks |
|---|---|---|---|
| API Intermediate Synthesis | High Purity, Low Moisture | Minimizes unknown process impurities and ensures reliable yield in regulated environments | Residual water or trace organics can interfere with catalyst or block crystallization |
| Agrochemical Intermediate | Technical Grade | Satisfactory for bulk reactions with additional downstream purifications | Organic trace impurities may affect overall process mass balance |
| Electronic Chemicals | Ultra-High Purity | Ensures minimal ion content and trace metals for sensitive photolithographic or etch applications | Impacts dielectric properties or etch uniformity if ionic impurities are outside customer limit |
| Academic/Laboratory Research | Research Grade or Above | Balances cost with consistent baseline for reproducibility in exploratory reactions | Batches with variable impurity profile complicate reproducibility and assignment of results |
Grade selection always ties back to batch-specific properties that most affect the system—such as main component assay, moisture, organic carbonyl impurities, residual solvents, halide/metal content, and optical quality for specialty uses. Manufacturing observes that during scale production, batch-to-batch moisture levels fluctuate depending on process drying and tank turnover rates. Trace byproducts from incomplete trifluoroacetylation or side-acylation occur, and handling steps post-reaction (including distillation route and storage tank design) dictate presence of light-ends or heavies.
Producers track impurity profiles using in-process chromatography and manage raw feedstock consistency to bound risk. Technical grade offers broader tolerances in main content and byproducts, which remains practical when customer purification follows. Tight-release pharmaceutical grades enforce spectroscopic and chromatographic impurity cutoff and often demand vendor-to-vendor harmonization for audit traceability.
Specific use clarifies the level of criticality. Producers request application details early in engagement. For downstream regulated APIs, specifying step in the synthesis route helps the plant adjust final homogeneity, packaging constraints, and traceability requirements.
Regulatory region sets baseline on allowable impurity profile and batch documentation. US FDA or EMA-driven supply chains use different supporting technical files. These drive in-plant QC batch release, especially for mutagenic or heavy metal concern.
Technical staff work with the customer to rank key purity areas that influence the overall result. Main component assay, water content, and major byproducts are directly adjusted by line operation control. For electronics or high-purity research, ionic and total metal screening test frequency increases.
Production scale and annual usage help weigh up the cost of higher-purity production, packaging, and analytical controls. Bulk users of technical grade frequently rely on local distillation and can accept broader specification. Small-lot pharmaceutical or specialty users often demand tighter batch reservation with additional segregation at bottle/blister packaging.
For new development, most customers request multi-batch split samples. Real-world trials in pilot plant or QA/QC environment allow benchmarking of solubility, reaction conversion, and impact on yield. Verification at this stage tests actual impurity fingerprint against known process limits.
Raw material control pivots on analytical confirmation of both main reactant purity and secondary contaminants such as residual acids or mineral content. During coupling stages, side-reactions contribute minor organic impurities unique to each lot. Byproduct fingerprinting uses both GC and LC, and downstream distillation selection tightens or broadens batch purity windows.
Batch consistency management involves cross-batch blending or splitting, monitored each shift by in-house analytics. Release criteria reflect a mix of baseline technical minimums and customer/market-driven overlays. Any out-of-limit impurity or unexpected quality drift prompts root cause investigation at both raw material receiving and in-process sampling points.
Production teams regularly review QC feedback to adjust fine purification, modify drying cycles, or change storage protocols based on batch-specific findings. Each grade is engineered to balance purity, process safety, cost, and end-use reliability. Sustainability goals in sourcing raw material and waste minimization at neutralization and emission points remain part of supplier selection and process improvement.
Core production relies on strict adherence to regulated quality management frameworks. Manufacturing sites are typically audited for ISO 9001 compliance. Certification provides external validation of management systems for documentation, batch traceability, and deviation control. Auditors examine raw material sourcing, equipment cleaning practices, record retention, and responses to non-conformance. Consistent surveillance audits help ensure routine practices stay aligned with evolving regulatory standards and customer requirements.
Demand for m-Trifluoromethylacetophenone in regulated sectors sometimes drives requests for documentation such as REACH registration, compliance origin statements, or customer-specific specifications. For industries such as pharmaceuticals or agrochemicals, material often receives additional scrutiny. This may involve third-party impurity analysis, elemental screening, or documentation of known route-dependent byproducts. Certification scope will depend on the grade and final application. Technical teams respond to these needs by maintaining updated reference documentation and issuing declarations based on current batch analytical data.
Standard documentation provided on request includes the certificate of analysis (CoA) referencing internal lot QC data. Customers requiring extended documentation can request impurity profiles, process flow diagrams, raw material origin records, and details on traceability logic. Document control systems maintain version history for all such records. Detailed release criteria depend on negotiated specification agreements, which can reference grade, region, and end-use application. Product data sheets and technical dossiers support customer regulatory filing when required.
Ongoing investment in production scale equipment and backup unit operations supports stable supply commitments. Dedicated synthesis lines for m-Trifluoromethylacetophenone minimize schedule conflicts with other campaigns, which helps maintain steady lead times. Strategic raw material sourcing contracts further reinforce reliability, addressing volatility in supply chain risk. Volume agreements with customers result in prioritized batch scheduling, and deviation management practices are disclosed transparently through the order process.
The main plant’s rated batch output and campaign frequency define achievable delivery schedules. Systematic review of batch-to-batch yield and impurity trend reporting drives improved forecast accuracy for raw material requirements and finished product lot release. For critical material users, direct scheduling access and inventory reservation mechanisms are supported. These technical and operational controls are regularly stress-tested during audits and customer performance reviews, with reporting on historical on-time delivery and deviation incident history.
For evaluation or registration sample needs, a documented request is submitted to technical support via the dedicated application channel. Samples are selected based on customer-disclosed end-use and required specification parameters. Each trial sample ships with the corresponding lot CoA and available documentation package. Feedback from trial results feeds directly into production refinement and customer support; requested sample volumes and accompanying data can be tailored according to customer risk assessment or validation requirements.
Procurement partnerships can adapt to changes in project startup, scaling demand, or region-specific compliance. Options include fixed-term offtake contracts, rolling purchase plans with just-in-time delivery, and collaborative stock management for downstream visibility. For R&D or pilot-scale quantities, expedited production slots and custom packaging provisions are supported. Contractual mechanisms accommodate bulk orders, sample requests, and multi-destination shipping, managed by a joint planning team that reviews capacity, documentation, and compliance together with the customer to align supply with specific industrial or regulatory challenges.
Across our technical teams, current R&D priorities for m-Trifluoromethylacetophenone center on three points: scalability in synthesis, minimization of byproduct formation, and adaptation for new pharmaceutical intermediates. Production managers have identified that optimizing the para- and ortho- substitution patterns on feedstock aromatic rings substantially reduces impurities that are structurally close to the target compound. Chemists are expanding the investigation into alternative fluorination sources to reduce corrosive reagent burdens on equipment, especially for continuous process operations.
Market feedback from direct downstream clients in pharmaceutical and agrochemical sectors highlights increasing adoption of m-Trifluoromethylacetophenone as a key building block for new heterocyclic compounds. In the past year, technical sales support recorded a marked uptick in custom inquiries for derivatives intended for emerging crop protection actives and specialty drug precursors, reflecting a broader trend toward fluorine-enriched fine chemicals. Internal application labs have also begun pilot trials exploring its use in polymer modification, though final outcomes remain application-dependent.
In industrial production, the primary challenge involves regioselective trifluoromethylation that consistently favors the meta position over ortho or para positions. Production lot data indicate that impurity levels from off-target trifluoromethylation become more prominent as process scales increase. Continuous efforts in process intensification—particularly real-time monitoring of reactant ratios and substitution control—have reduced batch-to-batch variability compared to legacy semi-batch protocols. Analytical QC teams achieve improved discrimination using targeted HPLC methods developed to quantify minor regioisomeric impurities. Incremental breakthroughs in purification, notably phase-separation assisted crystallization, have improved overall purity profiles for pharmaceutical-grade requests.
Based on historical order data, customer pipeline reviews, and direct requests for technical collaboration, demand for m-Trifluoromethylacetophenone continues to rise, driven by the expansion of proprietary API syntheses in North America and East Asia. Regulatory submissions for new fluorinated intermediates suggest a supply requirement shift favoring higher-purity and specification-tailored lots over commodity volumes. Market volatility is expected around upstream raw material pricing, but longer-term contracts with core customers provide production planning stability.
Process engineers see a clear movement toward integrated continuous-flow production models. Conversion rates under these systems now approach batch performance, with notable gains in yield consistency and solvent recovery efficiency. Ongoing dual-focus R&D—raw material analytics and catalytic trifluoromethyl group installation—continues to split between incremental upstream improvements and application-specific downstream tailoring. End-user feedback loops now influence specification tuning at the grade-release level, pushing the technical frontier away from single-standard “commodity” benchmarks.
Sourcing teams prioritize raw materials based on fewer halogenated byproducts and prefer supply partners with closed-loop HF and fluorine management. Process safety teams track accountability for solvent usage and promote alternatives to classic chlorinated or ether-based process media. Internal audits over the past cycle document the integration of several waste stream minimization projects, including in-plant recycling of fluorinated mother liquors where product grade allows. Green chemistry principles increasingly incorporate lifecycle assessment for every new process revision, with technical files updated to reflect evolving sustainability metrics per customer segment.
Direct technical consulting support is coordinated by chemists and process engineers familiar with both laboratory and industrial-scale synthesis of m-Trifluoromethylacetophenone. Consultation addresses synthesis route evaluation, impurity profiling specific to customer-selected grade or application, and guidance on optimal storage and dispensing practices for different container types. For new downstream processes, staff provide technical feasibility reviews based on prior plant-scale experiences, both for standard and custom derivatives.
Application teams support process transfer and scale-up for clients across pharmaceutical, agrochemical, and materials sectors. For pharma-intermediate grades, support often involves collaborative impurity mapping and bench-scale optimization of isolation steps according to each customer’s unique process configuration. Regular field feedback enables application engineers to recommend specific batch release standards, ensuring compatibility with customer purification requirements. Feedback from pilot trials assists in iterative refinement of supply lots, minimizing the risk of process bottlenecks downstream.
Support professionals track batch release documentation, provide root-cause analysis in the event of technical deviation, and coordinate rapid resolution with internal QC and manufacturing managers. The after-sales team responds to process troubleshooting queries, coordinating with technical and supply chain staff to facilitate urgent batch resupply if required. All after-sales engagement draws directly on historical batch data and technical archives maintained for every product grade, enabling accurate, experience-based recommendations and rapid action.
As the direct producer of m-Trifluoromethylacetophenone, our facility has focused on building a consistent, reliable chemical that supports a wide scope of industrial needs. Over years of production, our manufacturing processes have been tuned to meet stringent industrial buyer expectations, especially regarding reproducibility and supply reliability.
Our facility manages the entire life cycle of m-Trifluoromethylacetophenone, from raw material selection through dedicated batch synthesis, purification, and advanced filtration processes. Rigorous in-process monitoring ensures that every lot meets specified parameters for appearance, purity, and trace contaminant levels. All batches pass through analytical verification using approved chromatographic and spectroscopic techniques. By retaining full control from synthesis to packaging, we deliver reproducible quality to industrial buyers, reducing risk of downstream variability in core applications.
As an intermediate, m-Trifluoromethylacetophenone supports several core markets, particularly fine chemicals, pharmaceuticals, crop protection, and specialty materials. In pharmaceutical manufacturing, the trifluoromethyl group offers well-documented metabolic stability and electron-withdrawing properties for active ingredient synthesis. Agrochemical formulators use it in building blocks for innovative compounds with improved performance profiles. Our direct production control simplifies integration into continuous manufacturing and batch synthesis lines, reducing costs tied to qualification and revalidation.
Producing m-Trifluoromethylacetophenone in a closed-cycle digital environment delivers tight lot-to-lot consistency. Quality assurance tracks impurity profiles to ppm levels and investigates every non-conformity based on historic benchmarks and customer feedback. We analyze stability under typical industrial storage and transport conditions, and benchmark our product’s chemical footprint against leading industry data. As a result, procurement teams and technical managers can reduce their risk of process failures and handle process scale-up with greater predictability.
We utilize robust, chemically compatible packaging with tamper-evident closures to support both local and overseas bulk shipments. Every drum and container meets international transport guidelines for hazardous chemicals. Batch codes and labelling give traceability back to production data. Bulk customers can request quantity-adjusted shipments and coordinated delivery schedules, removing logistical uncertainty for project-driven or high-volume operations.
Our technical team brings hands-on process experience to support plant-scale integration. We troubleshoot compatibility with solvents, catalysts, and formulation additives. Detailed product documentation supports validation for regulated industries. Our lab can perform batch-specific reanalysis if process engineers or quality managers request additional data related to a specific project. This direct support structure creates a clear path from inquiry to industrial use, saving time and resources across the chain.
Manufacturers, distributors, and procurement specialists gain from direct engagement with production. Decision making benefits from full transparency into supply continuity, lead times, and technical alignment. Distributors and end users can align inventory strategies based on real-time insights into plant scheduling and capacity expansions. This level of visibility gives buyers a measurable edge in forecasting, budgeting, and long-term supply risk management.
Our role as a manufacturer places us at the center of industrial value delivery for m-Trifluoromethylacetophenone. Continuous investment in process technology, technical support, and customer-driven flexibility provides a foundation for reliable commercial partnerships in the chemical industry.
Over many years of manufacturing m-Trifluoromethylacetophenone, our technical team has seen strong demand from laboratories and researchers who place purity at the core of their work. This compound, with its trifluoromethyl group attached in the meta position, acts as a versatile building block in both pharmaceutical research and fine chemical synthesis. Its performance and reliability in analytical applications trace directly to the precision and quality control at the manufacturing site.
For analytical applications, specialists often expect an assay of m-Trifluoromethylacetophenone above 98%. We run every production batch through high-performance liquid chromatography (HPLC) methods calibrated against recognized analytical standards. Our output usually falls between 98% and 99.5%, which meets or exceeds the specifications required by most analytical laboratories. This range comes from direct, quantitative testing at each production step. Any trace-level impurities—even below 1%—can cause significant issues for customers working at ppm or ppb thresholds, so our laboratory team tracks not only the main component but also byproducts and trace contaminants.
By controlling critical process parameters and selecting high-quality starting materials, our factory minimizes risks of unknown impurities. Typical impurities may include positional isomers or residual starting materials from the Friedel-Crafts acylation route. Our analytical lab monitors these using both chromatographic and spectroscopic tools, ensuring none exceed the tightest tolerances demanded by research and diagnostic customers. This close-loop between manufacturing and QC keeps every lot consistent and ready for high-precision analytical use.
Difficulties arise during prolonged storage or exposure to air and light, which may degrade sensitive ketones. Our packaging line responds with amber glass bottles or high-barrier containers, flushed with inert gas, and sealed tightly. This step helps our chemical maintain both its purity and stability throughout shipment and storage. For bulk orders, stainless steel drums and customized packing are available to prevent contamination and preserve quality across the supply chain.
Some end users operate in regulated environments, where impurity profiles, heavy metals, and residual solvent levels undergo detailed scrutiny. We can provide detailed impurity breakdowns and certificates of analysis for every batch. Our documentation supports method validation and traceability in both routine QC and regulated projects.
In our experience, analytical customers benefit from direct access to manufacturing expertise. We offer in-depth application support, technical troubleshooting, and requalification of material against custom method parameters. If a unique purity requirement or special impurity specification arises, our development team can adjust process conditions or provide targeted purification steps to deliver tailor-made solutions.
Assay specification does more than fill a line on a certificate—it drives reliable results and defensible data for our customers. By holding our m-Trifluoromethylacetophenone consistently above 98% assay, and maintaining rigorous quality controls throughout the production chain, we aim to support success at every level of analytical science.
Securing m-Trifluoromethylacetophenone in quantities suited for industrial scale-up demands more than just a supply agreement. As the actual manufacturer of this intermediate, we encounter requests daily from R&D teams scaling to pilot runs and finished goods producers expanding capacity. Traditional laboratory packaging does not meet production throughput. Large-volume synthesis, downstream reactors, and continuous processing push us to think well beyond bottles and drums.
Our process starts with understanding exactly where the product needs to go and how it integrates into customer operations. We produce m-Trifluoromethylacetophenone through a route optimized for purity and batch consistency. From there, we focus on packaging formats that keep handling safe, reduce exposure risk, and allow for efficient transfers into process equipment. Steel drums with tamper-evident closures, HDPE lined containers for solvent resistance, and intermediate bulk container (IBC) units serve as our standard bulk options. For producers scaling upwards, we can load in customized capacities ranging from 25 kg up to several hundred kilograms per container or tote.
Managing the supply chain for a compound like m-Trifluoromethylacetophenone brings its own set of challenges. Stringent quality demands stand at the forefront. Any trace impurities carried in the packaging phase can compromise the outcome in fine chemical or pharmaceutical synthesis. To address this, we clean and inert all bulk packaging prior to loading. Each drum or IBC passes inspection by our in-house QA team. Lot-specific documentation provides traceability right back to the production batch.
Bulk packaging not only helps our customers scale, but reduces costs related to logistics, handling, and waste disposal. Shipping larger containers means fewer individual units, simplified inventory management, and less packaging material going for disposal. Compliance with ADR, IMDG, or DOT regulations—especially for hazardous goods—goes into each shipment plan at our plant. We coordinate with logistics partners experienced in bulk chemicals, and our technical team reviews each supply route for temperature and safety requirements.
A recurring topic among existing partners centers on moisture and air sensitivity. The trifluoromethyl group gives our product strong electron-withdrawing properties, and excess water introduces risk for degradation. Every bulk unit, from drums to IBCs, receives air-tight, sealed closure systems. We offer nitrogen purging on request, which keeps the compound stable during long-duration transit or storage. Our experience in export markets taught us that environmental control in bulk packaging is no less critical than that in small-scale lab supply.
We also respond to requests for dedicated handling equipment, such as drum pumps or one-way valve fittings. For large industrial users, these adaptations reduce operator contact and integrate with automated charging systems. We keep a stock of such accessories in our plant, ready for dispatch with the next bulk delivery. For initial scale-up trials or pilot plants, our team advises on optimal packaging dimensions to match the reactor charge volume, supporting a smooth ramp-up from kilo lab to full-scale production without excess waste or product loss.
Supplying m-Trifluoromethylacetophenone in bulk is more than a matter of filling large drums. It requires technical experience, regulatory compliance, deep knowledge of chemical compatibility, and ongoing commitment to customer process success. We adapt our packaging and shipping programs for each commercial project. Our customers rely on us for consistent quality, supply chain reliability, and the flexibility to meet evolving production targets, year after year.
From a manufacturer's perspective, any inquiry into the shipping conditions and regulatory classification for m-Trifluoromethylacetophenone deserves clarity grounded in both practical experience and compliance with established global standards. This chemical, recognized for its value in pharmaceutical and fine chemical synthesis, must move through the supply chain seamlessly while prioritizing safety and regulatory alignment.
Our production site operates under strict adherence to the Globally Harmonized System (GHS) and local transportation regulations. m-Trifluoromethylacetophenone, featuring a trifluoromethyl group, finds listing in comprehensive chemical databases and shipping regulations. Across years of manufacturing and exporting this compound in multi-ton volume, we track all relevant classification updates. In most jurisdictions—including the EU and North America—this material does not fall into the most dangerous classes for shipping, but does warrant hazard labeling as per GHS for its irritant and environmental hazard properties. This triggers specific packaging, labeling, and documentation during preparation for dispatch.
All shipments leaving our factory include a Safety Data Sheet drawn up to the latest GHS revision, covering classification, handling, and emergency advice. For air and sea transport, we provide a compliant Dangerous Goods Declaration where required by IATA and IMDG codes. Our logistics team vigilantly monitors threshold quantities, as larger shipments may elevate documentation requirements or attract additional checks during customs clearance. We attach all hazard pictograms where toxicity, combustibility, or environmental risk thresholds apply; on-site, our packing team verifies each carton to ensure nothing leaves our loading bay out of compliance.
From a stability standpoint, m-Trifluoromethylacetophenone does not require refrigeration or special atmosphere during transit. Our experience has shown that standard ambient temperatures suit this compound for both short domestic hauls and overseas shipments. We utilize sealed fluoropolymer or HDPE containers, ensuring no interaction with the contents and no vapor loss. Each batch is sealed immediately post-synthesis, minimizing headspace to control evaporation and odor. Absence of extreme flammability or reactivity reduces transit risk, yet all containers carry both substance name and hazard warning for first responders and warehouse personnel.
We operate a hardened chain of custody for every consignment, employing tamper-evident seals and digital recordkeeping for batch tracing. From finished goods release to final receipt, we capture the journey across warehouses, road, air, or sea carriers. Should regulations in the destination country change, our compliance team adjusts documentation and labels to meet those laws before dispatch. In markets where customs holds can occur, such as ports with heightened chemical controls, our support staff proactively supply all requested compliance filings in advance. This offers importers seamless customs release and uninterrupted production schedules.
Our direct communication channels remain open for technical support from packaging engineers and regulatory specialists. If unusual shipping requirements arise—such as shipment through high-temperature environments or extended storage in depots—we can provide custom packing solutions or enhanced ventilation packaging to maintain product quality. Clients with internal requirements for bulk handling or repacking also receive guidance on secondary packaging and container compatibility, based on field feedback and in-house laboratory studies.
As a direct manufacturer, we combine hands-on experience, regulatory awareness, and attention to shipping security to preserve product integrity from our plant gate to the end user’s storage facility. Our practices aim to streamline compliance, prevent accidents, and keep customers’ operations running without costly delays. We source knowledge from ongoing batch production, feedback from global logistics partners, and regulatory updates, keeping our shipment process robust and current.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
